Ex-NIH Director Lifted conflict of interest rules, Now favors limits on Drug-Company Ties – LAT Sun, 14 Mar 2004 Former Director of the National Institutes of Health, Harold Varmus, MD, appeared before a blue ribbon panel convened by his former agency, ostensibly to shed light on conflict of interest at…
Suicide in Psych Drug Trials: FDA Orwelian doublespeak – Insight Magazine Date: Mon, 14 Oct 2002 Insight Magazine’s interview with Dr. Thomas Laughren, team leader for the neuropharmachological drug-products division of the FDA, shows that FDA was caught off guard when Dr. Arif Khan independently analyzed FDA’s data revealing that…
Testing Psychotropic Drugs in Children April 30, 2002 David Healy, MD University of Wales College of Medicine April 30th 2002. The background against which this paper is prepared is that in 1997 I organized, chaired and wrote up the recommendations from an International Roundtable Meeting for the British Association for…
Someone Tell Brooke Shields the Truth!! Mon, 4 Jul 2005 On this American independence day, thousands of families strive for drug free schools–and they’re not worrying about illegal drugs, their main concern is coercive prescribed amphetamines and other mind-altering psychotropic drugs. Other than the critical reaction of actor Tom Cruise,…
Epidemiologist Says Most Published Research Findings Are False – Psychiatrist Addresses Credibility Crisis Sat, 8 Oct 2005 An article published in PLoS Medical (an Open Access Peer Reviewed Medical Journal) by an epidemiologist who holds academic positions on both sides of the Atlantic–at the University of Ioannina (Greece) and Tufts…
An Open Letter to Officials of the National Institute of Mental Health Fri, 30 Apr 2004 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Promoting openness and full disclosure https://ahrp.org From: Vera Hassner Sharav, President David Cohen, Ph.D. Secretary The ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) To: Thomas Insell, MD,…
FDA Issues Public Health Advisory Entitled Reports Of Suicidality in Pediatric Mon, 27 Oct 2003 The FDA issued a warning about the suicide risk for children prescribed an antidepressant of the SSRI class. These drugs have never been shown to be more effective than placebo for the treatment of depression–which…
27 April 2004 Background Information Representative, U.S. The Honorable Mr. Joe Barton, United States House of Representatives. Washington DC. Representative, U.S. The Honorable Mr. James Greenwood, United States House of Representatives, Washington DC. Number of US Citizens at Risk to SSRIs This letter is to advise you that there is…
NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, 2 Jun 2004 The New York Times saw fit to print a report about preliminary, unpublished findings of a study whose authors claim to have “found that Prozac helps teenagers overcome depression far…
Suicide Rate Unchanged in 10 Years–JAMA / AMA Considers Stand Against Warning Labels on Antidepressants Thu, 9 Jun 2005 A major report in the Journal of the American Medical Association shatters all claims about the effectiveness of antidepressants as a treatment for the prevention of suicide. A comparison of the…
Two-thirds foster care children in Mass on psych drugs_Globe Psychiatry: Soviet Experience–American Fallacy Wed, 11 Aug 2004 The Boston Globe reports that 2/3 of children in state care in Massachusetts are being “treated” for mental illness with psychotropic drugs. Marie Parente, a legislator, and parents call for disclosure of “how…
Just Say No – Forbes Tue, 16 Nov 2004 When Mrs. Nancy Reagan coined the phrase, Just Say No, she was referring to illicit drug pushers. The current Forbes cover story–Just Say No–refers to the prescription drug industry. "In a perverse kind of symbiosis, the cascade of disease and medical…
